Alzheimer's disease and its treatment by different approaches: A review

S Srivastava, R Ahmad, SK Khare - European Journal of Medicinal …, 2021 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …

A critical review of synthesis procedures, applications and future potential of nanoemulsions

A Naseema, L Kovooru, AK Behera, KPP Kumar… - Advances in Colloid and …, 2021 - Elsevier
Applications of nanotechnology in various spheres have increased manifold as it offers
solution to unsolved problems with higher effectiveness. Nanoemulsions are one such …

Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier

D Lee, T Minko - Pharmaceutics, 2021 - mdpi.com
Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …

Progress in nasal drug delivery systems

F Laffleur, B Bauer - International Journal of Pharmaceutics, 2021 - Elsevier
Most of the available drugs are usually administered orally (eg in tablets or capsules) or by
parenteral injection in the case of substances being destroyed in the gastric environment or …

Phytochemical delivery through nanocarriers: A review

R Ahmad, S Srivastava, S Ghosh, SK Khare - Colloids and Surfaces B …, 2021 - Elsevier
In recent times, phytochemicals encapsulated or conjugated with nanocarriers for delivery to
the specific sites have gained considerable research interest. Phytochemicals are mostly …

Improving drug delivery for Alzheimer's disease through nose-to-brain delivery using nanoemulsions, nanostructured lipid carriers (NLC) and in situ hydrogels

S Cunha, B Forbes, JM Sousa Lobo… - International journal of …, 2021 - Taylor & Francis
Current treatments for Alzheimer's disease (AD) attenuate the progression of symptoms and
aim to improve the patient's quality of life. Licensed medicines are mostly for oral …

Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis

L Li, R He, H Yan, Z Leng, S Zhu, Z Gu - Nano Today, 2022 - Elsevier
As a progressive, irreversible neurodegenerative disease, Alzheimer's disease (AD)
continues to be a serious public health problem worldwide. Currently, the most available …

Recent advances in the treatment of Alzheimer's disease using nanoparticle-based drug delivery systems

P Poudel, S Park - Pharmaceutics, 2022 - mdpi.com
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder.
Most existing treatments only provide symptomatic solutions. Here, we introduce currently …

[HTML][HTML] Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

B Singh, CM Day, S Abdella, S Garg - Journal of Controlled Release, 2024 - Elsevier
Abstract Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time,
exerting a significant impact on physical and mental health and leading to death. The …

Exosome-based approaches in the management of Alzheimer's disease

R Kandimalla, M Saeed, N Tyagi, RC Gupta… - … & Biobehavioral Reviews, 2023 - Elsevier
Alzheimer's disease (AD) has been the most extensively studied neurological disorders that
affects millions of individuals globally and is associated with misfolding of proteins in the …